EcoDrugPlus

Histamine Receptor H1

Ensembl ID : ENSDLAG00005007404
Gene Symbol: HRH1
1 Cross references
186 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSDLAG00005020744
Gene Symbol: HDAC1
1 Cross references
250 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSDLAG00005021087
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSDLAG00005004350
Gene Symbol: HDAC11
1 Cross references
200 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSDLAG00005009118
Gene Symbol: HDAC2
1 Cross references
205 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSDLAG00005020620
Gene Symbol: HDAC8
1 Cross references
206 Possible Orthologues:

Hypocretin (Orexin) Receptor 2

Ensembl ID : ENSDLAG00005023564
Gene Symbol: HCRTR2
1 Cross references
201 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSDLAG00005007449
Gene Symbol: IKBKB
1 Cross references
198 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSDLAG00005002895
Gene Symbol: INSRA
1 Cross references
230 Possible Orthologues:

Insulin Receptor B

Ensembl ID : ENSDLAG00005009460
Gene Symbol: INSRB
1 Cross references
201 Possible Orthologues:

Insulin-Like Growth Factor 1a Receptor

Ensembl ID : ENSDLAG00005002853
Gene Symbol: IGF1RA
1 Cross references
206 Possible Orthologues:

Insulin-Like Growth Factor 1b Receptor

Ensembl ID : ENSDLAG00005021438
Gene Symbol: IGF1RB
1 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).